IRF2BP2 and prostate carcinoma: Interestingly, we found that menin could modulate apoptosis via interacting with IRF-2BP2 (interferon regulatory factor-2 binding protein 2) that was identified as an apoptotic protein and its knockdown leads to apoptosis of breast and prostate cancer cells but not of other cell types [36].